Literature DB >> 3762737

Endogenous dopamine release from tuberoinfundibular neurons: does calmodulin play any role?

G F Di Renzo, S Amoroso, M Taglialatela, L Annunziato.   

Abstract

The possible involvement of calmodulin in the process of endogenous dopamine (DA) release from arcuate-periventricular nuclei-median eminence fragments, containing tuberoinfundibular dopaminergic (TIDA) neurons, has been investigated in an in vitro incubation system. For this purpose the basal and K+-stimulated DA release was examined in the presence and in the absence of the different putative calmodulin antagonists, pimozide, trifluoperazine, penfluridol and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7). Trifluoperazine and pimozide in concentrations up to 100 microM were both uneffective in blocking K+-evoked DA release. Penfluridol in doses of 5 and 10 microM, did not prevent 35 mM K+-induced endogenous DA release. It was able to reduce K+-stimulated DA release only at the very large concentration of 100 microM. W-7 added in vitro to the hypothalamic fragments, prevented endogenous DA release evoked by 35 mM K+ in a dose-dependent manner. W-5, a chlorine deficient analogue of W-7, that interacts only weakly with calmodulin, failed to modify K+-stimulated endogenous DA release in doses up to 200 microM. All the putative calmodulin antagonists used in the present study did not induce any change of basal DA release. In conclusion the fact that most of the agents, except W-7, known to antagonize calmodulin-dependent processes in many biological systems failed to interfere with the release of endogenous DA from TIDA neurons seems to suggest that calmodulin does not play a crucial role in the process of DA release and that the inhibitory effect of W-7 on endogenous DA release may be better attributed to other mechanisms different from its anticalmodulin action.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3762737     DOI: 10.1007/bf00512933

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

1.  Letter: Catecholamines in the median eminence: new evidence for a major noradrenergic input.

Authors:  A C Cuello; A S Horn; A V Mackay; L L Iversen
Journal:  Nature       Date:  1973-06-22       Impact factor: 49.962

2.  Uptake and release of [3H]dopamine by the median eminence: evidence for presynaptic dopaminergic receptors and for dopaminergic feedback inhibition.

Authors:  D K Sarkar; P E Gottschall; J Meites; A Horn; R C Dow; G Fink; A C Cuello
Journal:  Neuroscience       Date:  1983-11       Impact factor: 3.590

3.  The possible role of calmodulin in the inhibition of prolactin secretion by dopaminergic antagonists.

Authors:  J E Merritt; S Tomlinson; B L Brown
Journal:  Life Sci       Date:  1983-08-29       Impact factor: 5.037

4.  Stimulation of Ca2+-dependent neurotransmitter release and presynaptic nerve terminal protein phosphorylation by calmodulin and a calmodulin-like protein isolated from synaptic vesicles.

Authors:  R J DeLorenzo; S D Freedman; W B Yohe; S C Maurer
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

Review 5.  Calmodulin plays a pivotal role in cellular regulation.

Authors:  W Y Cheung
Journal:  Science       Date:  1980-01-04       Impact factor: 47.728

6.  Calmodulin in neurotransmitter release and synaptic function.

Authors:  R J DeLorenzo
Journal:  Fed Proc       Date:  1982-05

7.  N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide(W-7), a calmodulin antagonist, also inhibits phospholipid-sensitive calcium-dependent protein kinase.

Authors:  R C Schatzman; R L Raynor; J F Kuo
Journal:  Biochim Biophys Acta       Date:  1983-01-04

8.  Differential drug effects on dopamine concentrations and rates of turnover in the median eminence, olfactory tubercle and corpus striatum.

Authors:  G A Gudelsky; E K Moore
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

9.  Possible role for calmodulin in insulin release. Studies with trifluoperazine in rat pancreatic islets.

Authors:  Y Krausz; C B Wollheim; E Siegel; G W Sharp
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

10.  N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.

Authors:  H Hidaka; Y Sasaki; T Tanaka; T Endo; S Ohno; Y Fujii; T Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.